Stockreport

BioAtla to Announce Third Quarter 2025 Financial Results and Provide Business Highlights on November 13, 2025

BioAtla, Inc.  (BCAB) 
PDF SAN DIEGO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Ac [Read more]